Myomo, Inc. (MYO)
| Market Cap | 73.04M |
| Revenue (ttm) | 38.63M |
| Net Income (ttm) | -5.81M |
| Shares Out | 35.98M |
| EPS (ttm) | -0.17 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 403,535 |
| Open | 2.110 |
| Previous Close | 2.080 |
| Day's Range | 2.030 - 2.150 |
| 52-Week Range | 2.020 - 7.170 |
| Beta | 1.41 |
| Analysts | Strong Buy |
| Price Target | 9.13 (+349.75%) |
| Earnings Date | Aug 5, 2025 |
About MYO
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the bra... [Read more]
Financial Performance
In 2024, Myomo's revenue was $32.55 million, an increase of 69.17% compared to the previous year's $19.24 million. Losses were -$6.18 million, -24.10% less than in 2023.
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for MYO stock is "Strong Buy." The 12-month stock price target is $9.13, which is an increase of 349.75% from the latest price.
News
Myomo Provides Highlights of Today's Investor & Analyst Day Event
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurol...
Myomo, Inc. (MYO) Q1 2025 Earnings Call Transcript
Myomo, Inc. (NYSE:MYO) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Tirth Patel - Alliance Advisors, Investor Relations Paul Gudonis - Chief Executive Officer Dave Hen...
Myomo Reports First Quarter 2025 Financial and Operating Results
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurol...
Myomo to Host Investor & Analyst Day Event on June 18, 2025
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurol...
Myomo to Report First Quarter 2025 Financial Results on May 7
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurol...
Myomo Launches the MyoPro® 2x
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company that offers improved arm and hand function for individuals with upper-limb paralysis and neuro...
Myomo Announces Upcoming Changes to its Board of Directors
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurol...
Myomo to Present at the 24th Annual Needham Virtual Healthcare Conference
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurol...
Myomo, Inc. (MYO) Q4 2024 Earnings Call Transcript
Myomo, Inc. (NYSE:MYO) Q4 2024 Earnings Conference Call March 10, 2025 4:30 PM ET Company Participants Tirth Patel - Alliance Advisors, Investor Relations Paul Gudonis - Chief Executive Officer Dave ...
Myomo's Fourth Quarter Financial Results Feature Record Revenue of $12.1 Million
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurol...
Myomo to Report Fourth Quarter 2024 Financial Results on March 10
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurol...
Myomo, Inc. Prices $15.0 Million Public Offering of Common Stock
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper l...
Myomo, Inc. Announces Proposed Public Offering of Common Stock
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper l...
Myomo, Inc. (MYO) Q3 2024 Earnings Call Transcript
Myomo, Inc. (MYO) Q3 2024 Earnings Call Transcript
Myomo Reports Record Third Quarter Financial and Operating Results
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
CMS Decision And O&P Network Build Out Make Myomo A Buy
Myomo's business model is now sustainable due to CMS reclassifying MyoPro, leading to lump sum payments and consistent insurance coverage. Medicare Part B coverage has significantly improved Myomo's o...
Myomo Announces First Private Payer Contracts for MyoPro In-network Coverage
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo to Report Third Quarter Financial Results on November 6, 2024
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo to Participate in the 2024 Maxim Healthcare Virtual Summit
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo, Inc. Announces the Launch of Myomo Academy at AOPA National Assembly
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo to Participate in Two Investor Conferences in September
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo, Inc. (MYO) Q2 2024 Earnings Call Transcript
Myomo, Inc. (NYSE:MYO) Q2 2024 Earnings Conference Call August 6, 2024 4:30 PM ET Company Participants Kim Golodetz - LHA Investor Relations Paul Gudonis - Chief Executive Officer Dave Henry - Chief ...
Myomo Reports Second Quarter 2024 Financial Results
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo to Report Second Quarter Financial Results on August 6, 2024
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...
Myomo Reports Preliminary Second Quarter 2024 Revenues and Operating Metrics
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...